You are currently viewing the EU version of the website.

View US version

en

Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)

On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with immediate effect.

MC-1022-EN-Rev-A_DDG-Statement-on-EndoTrial_English.pdf